{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:48:48Z","timestamp":1776872928109,"version":"3.51.2"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003486","name":"Hellenic Rheumatology Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clim.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T22:55:02Z","timestamp":1520290502000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis"],"prefix":"10.1016","volume":"193","author":[{"given":"Maira","family":"Giannelou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrianos","family":"Nezos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Fragkioudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Kasara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriaki","family":"Maselou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7545-8089","authenticated-orcid":false,"given":"Nikolaos","family":"Drakoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Ioakeimidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.02.014_bb0005","first-page":"87","article-title":"Mortality in systemic lupus erythematosus: the bimodal pattern revisited","volume":"55","author":"Rubin","year":"1985","journal-title":"Q. J. Med."},{"key":"10.1016\/j.clim.2018.02.014_bb0010","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0015","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2018.02.014_bb0020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2018.02.014_bb0025","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.14.7.1080","article-title":"High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis","volume":"14","author":"Falcon","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.clim.2018.02.014_bb0030","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(96)03032-2","article-title":"Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus","volume":"348","author":"Petri","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2018.02.014_bb0035","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2018.02.014_bb0040","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/CIRCULATIONAHA.108.808675","article-title":"MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis","volume":"119","author":"Antoniades","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2018.02.014_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.06.003","article-title":"Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians","volume":"176","author":"Kelemen","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clim.2018.02.014_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14728220802560281","article-title":"Serum total homocysteine, folate, 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C-->T genotype and subclinical atherosclerosis","volume":"13","author":"Panayiotou","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.clim.2018.02.014_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/art.21172","article-title":"Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors","volume":"53","author":"Afeltra","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0060","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/art.21967","article-title":"Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus","volume":"54","author":"Von Feldt","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/0961203307077988","article-title":"MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population","volume":"16","author":"Burzynski","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2018.02.014_bb0070","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3899\/jrheum.080071","article-title":"Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus","volume":"35","author":"Summers","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0075","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0085","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the systemic lupus international collaborating clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.20923","article-title":"Disease activity measurement of rheumatoid arthritis: comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine","volume":"53","author":"Leeb","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-015-0613-6","article-title":"Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations","volume":"17","author":"Gravani","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2018.02.014_bb0105","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1038\/s41598-017-07347-w","article-title":"MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome","volume":"7","author":"Fragkioudaki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2018.02.014_bb0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2018.02.014_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.2006.054973","article-title":"High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors","volume":"66","author":"Chung","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.02.014_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0961203309346906","article-title":"Oxidative stress and homocysteine metabolism in patients with lupus nephritis","volume":"19","author":"Moroni","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2018.02.014_bb0125","first-page":"76","article-title":"Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus","volume":"34","author":"Bonciani","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/qjmed\/89.8.571","article-title":"The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia","volume":"89","author":"Harmon","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.clim.2018.02.014_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2018.02.014_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00439-006-0290-2","article-title":"Functional inference of the methylenetetrahydrofolate reductase 677C > T and 1298A > C polymorphisms from a large-scale epidemiological study","volume":"121","author":"Ulvik","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clim.2018.02.014_bb0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2000-8471","article-title":"Biological and environmental determinants of plasma homocysteine","volume":"26","author":"Schneede","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.clim.2018.02.014_bb0150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s100670200115","article-title":"Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients","volume":"21","author":"Refai","year":"2002","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0155","first-page":"111","article-title":"A clinical study of hyperhomocysteinemia in rheumatological diseases","volume":"44","author":"Xu","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.clim.2018.02.014_bb0160","first-page":"1737","article-title":"Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study","volume":"25","author":"Fijnheer","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00296-004-0546-x","article-title":"Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis","volume":"26","author":"Tiftikci","year":"2006","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2018.02.014_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/ard.2003.019828","article-title":"Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate","volume":"64","author":"Hoekstra","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.02.014_bb0175","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","article-title":"Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis","volume":"41","author":"van Ede","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2018.02.014_bb0180","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","volume":"62","author":"Doria","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.02.014_bb0185","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clim.2018.02.014_bb0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13075-015-0790-3","article-title":"Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus","volume":"17","author":"Virdis","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2018.02.014_bb0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10067-005-0063-7","article-title":"A positive correlation between homocysteine and brachial-ankle pulse wave velocity in patients with systemic lupus erythematosus","volume":"25","author":"Tso","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0200","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.27392","article-title":"Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients","volume":"62","author":"Perna","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.38204","article-title":"A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus","volume":"66","author":"McMahon","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/acr.22271","article-title":"Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus","volume":"66","author":"Lertratanakul","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2018.02.014_bb0215","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1002\/art.22924","article-title":"Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus","volume":"56","author":"Roman","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0220","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.104349","article-title":"Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study","volume":"69","author":"Rua-Figueroa","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.02.014_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.06.009","article-title":"Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: a mechanistic and clinical perspective","volume":"78","author":"Santilli","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.clim.2018.02.014_bb0230","first-page":"1479","article-title":"Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia","volume":"30","author":"Tam","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0235","first-page":"163","article-title":"The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients","volume":"26","author":"Rubini","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0240","first-page":"106","article-title":"Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis","volume":"34","author":"Remuzgo-Martinez","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2018.02.014_bb0245","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/ard.2005.046797","article-title":"Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis","volume":"65","author":"Hughes","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.02.014_bb0250","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar2989","article-title":"A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis","volume":"12","author":"Palomino-Morales","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2018.02.014_bb0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.11418","article-title":"Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus","volume":"50","author":"Selzer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0260","first-page":"131","article-title":"Mannose binding lectin gene polymorphism and preclinical carotid atherosclerosis in patients with systemic lupus erythematosus","volume":"17","author":"El-Sherif","year":"2010","journal-title":"Egypt J. Immunol."},{"issue":"Suppl. 10","key":"10.1016\/j.clim.2018.02.014_bb0265","article-title":"B-cell activating factor genetic variants in systemic lupus erythematosus and lupus related atherosclerosis","volume":"68","author":"A","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.02.014_bb0270","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.ATV.17.6.1157","article-title":"The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes","volume":"17","author":"Malinow","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2018.02.014_bb0275","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1160\/TH11-12-0899","article-title":"Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C-->T polymorphism","volume":"108","author":"Dragani","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2018.02.014_bb0280","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618300020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618300020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T12:25:10Z","timestamp":1535027110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618300020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":56,"alternative-id":["S1521661618300020"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.02.014","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}